A recent market study published by the company – “Interventional Pulmonology Market: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026” consists of a comprehensive assessment of the most important market dynamics. By conducting a thorough research on the historical as well as current growth parameters of the Interventional Pulmonology market, the growth prospects of the market are obtained with maximum precision.
The report features unique and salient factors that may have a huge impact on the development of the Interventional Pulmonology market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the Interventional Pulmonology Market in the upcoming years. The report provides detailed information about the current and future growth prospects of the Interventional Pulmonology market in the most comprehensive way for better understanding of the readers.
Chapter 1 – Executive Summary
The report commences with the executive summary of the Interventional Pulmonology market, which includes the summary of key findings and statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the Interventional Pulmonology market.
Chapter 2 – Market Introduction
Readers can find detailed taxonomy and the definition of Interventional Pulmonology in this chapter, which will help them understand the basic information about the Interventional Pulmonology market dynamics, key players, supply chain analysis and value chain analysis are included in the report.
Chapter 3 – Market Opportunity Assessment
Readers can find details of macroeconomic factors and opportunities that the market has to offer.
Chapter 4 – Market Background
Readers can find details of the market dynamics including drivers, restrains, trends and value chain analysis that affects the Interventional Pulmonology market throughout the forecast period.
Chapter 5 – Key incisions
This chapter explains how the regulatory scenario affects the market globally, along with epidemiology data for some of the key diseases that affect the market growth. This chapter also contains details of the number of hospitals, clinics and ASCs along with the number of some of the key Interventional Pulmonology Procedures.
Chapter 6 – North America Interventional Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026
This chapter includes a detailed analysis of the growth of the North America Interventional Pulmonology market along with a country-wise assessment including the U.S. and Canada. Readers can also find regional trends, and market growth based on test type, service provider, and country for the Interventional Pulmonology market in North America.
Chapter 7 – Latin America Interventional Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026
The readers can find detailed information about factors that are impacting the growth of the Latin America Interventional Pulmonology market. This chapter also includes the growth prospects of the Interventional Pulmonology market in leading LATAM countries such as Brazil, Argentina and Rest of Latin America.
Chapter 8 – Europe Interventional Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026
Important growth prospects of the Interventional Pulmonology market based on its test types, along with service provider in several European countries, such as Germany, U.K., France, Italy, Spain, Russia and Rest of Europe.
Chapter 9 – APEC Interventional Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026
India, Japan, Australia, and New Zealand are the leading countries in the APEC region that are the prime subjects of assessment to obtain growth prospects of the APEC Interventional Pulmonology market in this chapter. The readers can find thorough information about the growth parameters of the APAC Interventional Pulmonology market during the period 2018-2026.
Chapter 10 – China Interventional Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026
The readers can find thorough information about the growth parameters of the China Interventional Pulmonology market during the period 2018-2026.
Chapter 11 – MEA Interventional Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026
This chapter provides information on how the Interventional Pulmonology market will grow in the major countries of the MEA region, such as Saudi Arabia, and South Africa, during the period 2018-2026.
Chapter 12 –Interventional Pulmonology Market: Competition Analysis
This chapter provides information on Market Structure, Market Share and Key market players strategy and product offering.
Chapter 13 – Global Interventional Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026, by Region
This chapter explains how the Interventional Pulmonology market will grow across various geographic regions, such as North America, Latin America, Europe, Asia-Pacific excluding China, China, and Middle East & Africa (MEA).
Chapter 14 – Global Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026, by Product Type
Based on the Product type, the Interventional Pulmonology market is segmented into Bronchoscopes, Respiratory Endo Therapy Devices, ENB Systems, Pleuroscopes, Airway Stents, Bronchial thermoplasty Systems, Pleural Catheters and Endobroncheal Valves. In this chapter, readers can find information about the key trends and developments in the Interventional Pulmonology market and market attractive analysis based on the type of product.
Chapter 15 – Global Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026, by Indication
Based on the Indication, the Interventional Pulmonology market is segmented into Astham, COPD, Lung Cancer, Foreign Body Removal, Tracheal and Bronchial Stenosis and Others. In this chapter, the readers can find information about the key trends and developments in the Interventional Pulmonology market and market attractive analysis based on Indication.
Chapter 16 – Global Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026, by End User
Based on the end user, the Interventional Pulmonology market is segmented into Hospitals, Ambulatory Surgical centers, Pulmonology Clinics and Diagnostic Centers. In this chapter, the readers can find information about the key trends and developments in the Interventional Pulmonology market and market attractive analysis based on end user.
Chapter 17 – Global Pulmonology Market Analysis 2013–2017 and Forecast 2018–2026
In this chapter, the readers can find information about the key trends and developments in the Global Interventional Pulmonology market and market attractive analysis.
Chapter 18 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.
Chapter 19 – Research Methodology
This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the Interventional Pulmonology market.
Increasing Number of Awareness Programs for COPD & Asthma Education & Treatment to Drive Interventional Pulmonology Market Growth
A number of awareness programs have been initiated by healthcare providers and other organizations and societies that include medication maintenance programs, online education programs for public and healthcare professionals, and environmental programs to increase awareness regarding the control of COPD, asthma, and other respiratory diseases. COPD is a non-curable disease; however, it can be managed with proper medication.
Such programs encourage people to adopt early medication, and this factor may result in the growth of revenue in the global interventional pulmonology market. Healthcare providers and organizations are teaming up to prevent respiratory diseases across the world, and also improve their treatment.
Rising COPD Cases across APAC to Boost Scope of Penetration for Interventional Pulmonology Procedures
Chronic obstructive pulmonary disease (COPD) is a broad term that is used to describe lung disorders that are chronic and progressive, such as chronic bronchitis and asthma. The prevalence of COPD cases in China is 3-4%, mainly due to an increase in biomass smoke exposure.
According to some research studies, approximately half a million deaths occur in India every year due to COPD. The WHO estimates a 10-17% prevalence in the total population in New Zealand. The Lung Foundation Australia estimates that 7.5% of Australians who are 40 years of age or above suffer from COPD.
There has been a rise in disposable income in the developing economies of Asia Pacific countries. Thus, increasing disposable income is expected to allow more number of people to make use of nebulizer devices. This factor is projected to drive the growth of the interventional pulmonology market in Asia Pacific.
Growing Overall Life Expectancy to Support the Growth of the Interventional Pulmonology Market
Improvement in healthcare policies in various countries, including the U.S. and Japan, further enhances the affordability for various diagnostic and treatment services. This has increased the life expectancy of the people. Rising life expectancy rate is another major factor that is expected to support the growth of the interventional pulmonology market, due to the high prevalence of COPD among the older population.
The population above 45 years of age is mostly prone to COPD, or one can say that the risk of respiratory diseases is higher among the aging population. Global population is projected to increase over time. Global population in 2015 was around 7.2 Bn, and is estimated to grow to 15 Bn by 2050.
People aged 65 and above is one of the fastest growing demographics across the globe. These factors are expected to increase the adoption of interventional pulmonology procedures, which, in turn, will support the growth of the interventional pulmonology market growth through the forecast period.
Cross Contamination and Post Bronchoscopy Infection to Affect Interventional Pulmonology Market Growth
The risks of cross-contamination and post bronchoscopy infection from bronchoscopy procedures are under researched, dampening adoption rates. Risks related to bronchoscopy such as bleeding, troubled breathing, and a low blood oxygen level during the test are also hampering the growth of the interventional pulmonology market.
The rate of a patient suffering from a post bronchoscopy infection has been rising, due to the emergence of methicillin-resistant staphylococcus aureus and other resistant bacteria. Post bronchoscopy infection rates at ambulatory surgical centers (ASCs) are many times higher than hospitals and clinics, which is hampering the growth of the interventional pulmonology market.
Competition from Alternative Methods and Growing Stringency of Regulations
The emergence of non-invasive diagnostic methods such as liquid biopsy, magnetic resonance spectroscopy, and others is negating the growth of the interventional pulmonology market. Growing stringency of regulations such as post marketing approval is hampering market growth. The average time taken for any device to reach the market is 3-7 years. Any Class III device needs to get a pre-market approval, which is one of the most stringent process for FDA approval of the device. Clinical trial evidence is required to support the application, owing to significantly greater risks to patients. Thus, the growing stringency of regulations is hampering the growth of the interventional pulmonology market.
Interventional pulmonology is a sub-segment of pulmonology medicine. Interventional pulmonology specifically deals with the minimally invasive endoscopic and percutaneous procedures used for the diagnosis and treatment of a number of respiratory disorders and diseases such as asthma, COPD, and lung cancer, among many others.
About the Report
The report offers a comprehensive evaluation of the business opportunities in the interventional pulmonology market, along with insights on the competition blueprint, value chain, list of manufacturers, and regulatory analysis of the interventional pulmonology market for the duration 2018 to 2026.
The report offers a comprehensive taxonomy of the interventional pulmonology market based on product type, indication, end user, and region. Based on product type, the global interventional pulmonology market is segmented into bronchoscopes, respiratory endotherapy devices, ENB systems, pleuroscopes, airway stents, bronchial thermoplasty systems, pleural catheters, and endobronchial valves.
Based on indication, the global interventional pulmonology market is segmented into asthma, lung cancer, COPD, foreign body extraction, and tracheal and bronchial stenosis. Based on end user, the global interventional pulmonology market is segmented into hospitals, pulmonology clinics, ambulatory surgical centers, and diagnostic centers. From a geographical perspective, the interventional pulmonology market is segmented into North America, Latin America, Europe, Asia Pacific excluding China (APEC), China, and the Middle East & Africa (MEA).
Additional Questions Answered
Some of the additional questions addressed in this report on the interventional pulmonology market are-